{
    "medicine_id": "771e22ca317e83a88e36ba8929e5f21bd69aac5c",
    "platform_id": "DB13249",
    "metadata": {
        "name": "Formula EC Tablet",
        "composition": "Magnesium silicate",
        "clinical_particulars": {
            "therapeutic_indications": "Magnesium silicate is used to absorb moisture prevent caking and to improve the feel of a product In the pharmaceutical companies it is used as a dietary supplement as part of the formulation ingredients in drug production in antacid and antiulcer preparations as a component of antiepileptic drugs in antifungal topical agents and in the treatment of acne and as a facial moisturizer L2603 When complexed with arginine magnesium silicate can be used as an antiatherosclerotic agent and to promote bone and cartilage formation in mammals T186",
            "contraindications": {
                "disease": "The administration of more than 50 meq of magnesium daily can produce the development of hypermagnesemia This can provoke the formation of bladder and renal calculi There is no known toxicity and the LD50 in animals are higher than 500 mg kg in humans T186 It is determined that magnesium silicate is not carcinogenic L2614",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00202",
                        "description": "The therapeutic efficacy of Succinylcholine can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The therapeutic efficacy of Cisatracurium can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The therapeutic efficacy of Rocuronium can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The therapeutic efficacy of Atracurium besylate can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The therapeutic efficacy of Mivacurium can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The therapeutic efficacy of Metocurine can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The therapeutic efficacy of Pancuronium can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The therapeutic efficacy of Pipecuronium can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The therapeutic efficacy of Vecuronium can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The therapeutic efficacy of Pyrantel can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The therapeutic efficacy of Neosaxitoxin can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The therapeutic efficacy of Atracurium can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The therapeutic efficacy of Gallamine can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The therapeutic efficacy of Alcuronium can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The therapeutic efficacy of Tubocurarine can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "The serum concentration of Cefditoren can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Erlotinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Magnesium silicate can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00136",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Calcitriol"
                    },
                    {
                        "drugbank-id": "DB00146",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Calcifediol"
                    },
                    {
                        "drugbank-id": "DB00169",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Cholecalciferol"
                    },
                    {
                        "drugbank-id": "DB00910",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB01070",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Dihydrotachysterol"
                    },
                    {
                        "drugbank-id": "DB01436",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Alfacalcidol"
                    },
                    {
                        "drugbank-id": "DB04258",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Seocalcitol"
                    },
                    {
                        "drugbank-id": "DB04796",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Inecalcitol"
                    },
                    {
                        "drugbank-id": "DB04891",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Becocalcidiol"
                    },
                    {
                        "drugbank-id": "DB05295",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Eldecalcitol"
                    },
                    {
                        "drugbank-id": "DB06117",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with 1alpha 24S Dihydroxyvitamin D2"
                    },
                    {
                        "drugbank-id": "DB06194",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Elocalcitol"
                    },
                    {
                        "drugbank-id": "DB06272",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Maxacalcitol"
                    },
                    {
                        "drugbank-id": "DB06410",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Doxercalciferol"
                    },
                    {
                        "drugbank-id": "DB11094",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with Vitamin D"
                    },
                    {
                        "drugbank-id": "DB13097",
                        "description": "The serum concentration of Magnesium silicate can be increased when it is combined with 1alpha Hydroxyvitamin D5"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Deferiprone resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01344",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09020",
                        "description": "The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "The serum concentration of Cefpodoxime can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "The serum concentration of Cefuroxime can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09101",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Elvitegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The serum concentration of Gabapentin enacarbil can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Rifampicin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Magnesium silicate may decrease the excretion rate of Mecamylamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Magnesium silicate may decrease the excretion rate of Memantine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Penicillamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Magnesium silicate may decrease the excretion rate of Quinidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Quinine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The serum concentration of Sotalol can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The therapeutic efficacy of Sulpiride can be increased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "The therapeutic efficacy of Allopurinol can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Fexofenadine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06817",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00929",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Misoprostol"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00847",
                        "description": "The bioavailability of Cysteamine can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Technetium Tc 99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11404",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Enrofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Orbifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Sarafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Difloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Rufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00256",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00453",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00595",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00618",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00931",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Sarecycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13264",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Penimepicycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Thiethylperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Promazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Prochlorperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Chlorpromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Triflupromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Thioridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Moricizine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Perphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Acetophenazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Promethazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Alimemazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Methotrimeprazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Periciazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Acepromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Aceprometazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Pipotiazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Thioproperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "Magnesium silicate can cause a decrease in the absorption of BL 1020 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Cyamemazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Methylene blue resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Propiopromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Perazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Butaperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Chlorproethazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Thiazinam resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Dixyrazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Perphenazine enanthate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06799",
                        "description": "The therapeutic efficacy of Methenamine can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The serum concentration of Pamidronic acid can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00399",
                        "description": "The serum concentration of Zoledronic acid can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The serum concentration of Alendronic acid can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The serum concentration of Ibandronate can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00720",
                        "description": "The serum concentration of Clodronic acid can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The serum concentration of Risedronic acid can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01077",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "The serum concentration of Tiludronic acid can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB06255",
                        "description": "The serum concentration of Incadronic acid can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The bioavailability of Betamethasone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The bioavailability of Fluticasone propionate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The bioavailability of Triamcinolone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The bioavailability of Prednisone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The bioavailability of Fludrocortisone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The bioavailability of Hydrocortisone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The bioavailability of Prednisolone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The bioavailability of Methylprednisolone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The bioavailability of Trilostane can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The bioavailability of Budesonide can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The bioavailability of Dexamethasone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The bioavailability of Cortisone acetate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The bioavailability of Paramethasone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The bioavailability of Aldosterone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The bioavailability of Fluprednidene can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The bioavailability of Fluprednisolone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The bioavailability of Meprednisone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The bioavailability of Melengestrol can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The bioavailability of Deflazacort can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The bioavailability of Cortivazol can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The bioavailability of Prednylidene can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The bioavailability of Fluocortin can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The bioavailability of Fluperolone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The bioavailability of Cloprednol can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The bioavailability of Fluclorolone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14541",
                        "description": "The bioavailability of Hydrocortisone cypionate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The bioavailability of Prednisolone phosphate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The bioavailability of Prednisone acetate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The bioavailability of Clocortolone acetate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The bioavailability of Melengestrol acetate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The bioavailability of Betamethasone phosphate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The bioavailability of Cortisone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The bioavailability of Clobetasol propionate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The bioavailability of Fluocinonide can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The bioavailability of Mometasone furoate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The bioavailability of Hydrocortisone butyrate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The bioavailability of Ciclesonide can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The bioavailability of Desoximetasone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The bioavailability of Fluticasone furoate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The bioavailability of Fluocinolone acetonide can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The bioavailability of Fluocortolone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The bioavailability of Beclomethasone dipropionate can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The bioavailability of Difluocortolone can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of hypotension can be increased when Isradipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of hypotension can be increased when Diltiazem is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of hypotension can be increased when Trimethadione is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "The risk or severity of hypotension can be increased when Amlodipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of hypotension can be increased when Nimodipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "The risk or severity of hypotension can be increased when Nisoldipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The risk or severity of hypotension can be increased when Lercanidipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of hypotension can be increased when Lamotrigine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of hypotension can be increased when Cinnarizine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of hypotension can be increased when Ethosuximide is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of hypotension can be increased when Nicardipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The risk or severity of hypotension can be increased when Magnesium sulfate is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The risk or severity of hypotension can be increased when Verapamil is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of hypotension can be increased when Loperamide is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of hypotension can be increased when Zonisamide is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of hypotension can be increased when Felodipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of hypotension can be increased when Nitrendipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of hypotension can be increased when Perhexiline is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of hypotension can be increased when Nifedipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of hypotension can be increased when Amiodarone is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The risk or severity of hypotension can be increased when Carvedilol is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of hypotension can be increased when Bepridil is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of hypotension can be increased when Mibefradil is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of hypotension can be increased when Nimesulide is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of hypotension can be increased when Prenylamine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "The risk or severity of hypotension can be increased when Cyclandelate is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of hypotension can be increased when Flunarizine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of hypotension can be increased when Fluspirilene is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The risk or severity of hypotension can be increased when Clevidipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of hypotension can be increased when Methsuximide is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "The risk or severity of hypotension can be increased when Seletracetam is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of hypotension can be increased when Nylidrin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of hypotension can be increased when Ziconotide is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of hypotension can be increased when Dotarizine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of hypotension can be increased when Nilvadipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of hypotension can be increased when Tranilast is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "The risk or severity of hypotension can be increased when Fasudil is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The risk or severity of hypotension can be increased when Agmatine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of hypotension can be increased when Fendiline is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of hypotension can be increased when Eperisone is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of hypotension can be increased when Trimebutine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of hypotension can be increased when Pinaverium is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of hypotension can be increased when Tolfenamic acid is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "The risk or severity of hypotension can be increased when Barnidipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of hypotension can be increased when Aranidipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "The risk or severity of hypotension can be increased when Azelnidipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of hypotension can be increased when Benidipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "The risk or severity of hypotension can be increased when Cilnidipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "The risk or severity of hypotension can be increased when Darodipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of hypotension can be increased when Efonidipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of hypotension can be increased when Lacidipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The risk or severity of hypotension can be increased when Manidipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of hypotension can be increased when Niguldipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "The risk or severity of hypotension can be increased when Niludipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "The risk or severity of hypotension can be increased when Carboxyamidotriazole is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of hypotension can be increased when Naftopidil is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of hypotension can be increased when Tetrahydropalmatine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of hypotension can be increased when Vinpocetine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of hypotension can be increased when Gallopamil is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of hypotension can be increased when Bencyclane is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of hypotension can be increased when Otilonium is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of hypotension can be increased when Terodiline is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of hypotension can be increased when Lidoflazine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of hypotension can be increased when Penfluridol is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "The risk or severity of hypotension can be increased when Caroverine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of hypotension can be increased when WIN 55212 2 is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "The risk or severity of hypotension can be increased when Fish oil is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of hypotension can be increased when Dexverapamil is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "The risk or severity of hypotension can be increased when Emopamil is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "The risk or severity of hypotension can be increased when Lomerizine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of hypotension can be increased when Tetrandrine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The risk or severity of hypotension can be increased when Dexniguldipine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The serum concentration of Amphetamine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The serum concentration of Phentermine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The serum concentration of Pseudoephedrine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The serum concentration of Benzphetamine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The serum concentration of Diethylpropion can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The serum concentration of Lisdexamfetamine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The serum concentration of Mephentermine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The serum concentration of MMDA can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The serum concentration of Midomafetamine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The serum concentration of 2 5 Dimethoxy 4 ethylamphetamine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The serum concentration of 4 Bromo 2 5 dimethoxyamphetamine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The serum concentration of Tenamfetamine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The serum concentration of Chlorphentermine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "The serum concentration of Methylenedioxyethamphetamine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The serum concentration of Dextroamphetamine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The serum concentration of Metamfetamine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The serum concentration of Iofetamine I 123 can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The serum concentration of Ritobegron can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The serum concentration of Mephedrone can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The serum concentration of Methoxyphenamine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The serum concentration of Gepefrine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The serum concentration of 2 5 Dimethoxy 4 ethylthioamphetamine can be increased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB06783",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Prussian blue resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09146",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09501",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09507",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferumoxsil resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09508",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferumoxides resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11171",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferric sulfate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11210",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferrous bisglycinate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11417",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Gleptoferron resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12821",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Perflubutane resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13257",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13381",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Sodium feredetate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13423",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferric hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13949",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferric cation resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14488",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferrous gluconate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14489",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferrous succinate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14491",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferrous fumarate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14520",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14695",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferric oxyhydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00893",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01592",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB15598",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferric maltol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14523",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Phosphate ion resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02369",
                        "description": "Magnesium silicate can cause a decrease in the absorption of 3 Aza 2 3 Dihydrogeranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02423",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Thiopyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02552",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Geranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04160",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05143",
                        "description": "Magnesium silicate can cause a decrease in the absorption of OXI 4503 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Geranylgeranyl diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09147",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Monopotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09414",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Sodium phosphate monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11493",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Sodium tripolyphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13995",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ferric pyrophosphate citrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14481",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Cyclosporine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Capreomycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Piperacillin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00560",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Tigecycline is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Tobramycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Gentamicin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Etacrynic acid is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Netilmicin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Procainamide is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Streptomycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Colistimethate is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Kanamycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Dantrolene is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01301",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Rolitetracycline is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01378",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium cation is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Paromomycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01627",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Lincomycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Ribostamycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Geneticin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Apramycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Gentamicin C1a is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Neamine is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Arbekacin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB06827",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Viomycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Puromycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium hydroxide is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium trisilicate is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium chloride is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09409",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium acetate tetrahydrate is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium carbonate is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium citrate is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB11189",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium glycinate is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB11230",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium Aluminum Silicate is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Dihydrostreptomycin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Hygromycin B is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Sisomicin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Plazomicin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13359",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium silicate is combined with Magnesium aspartate"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium silicate is combined with Isepamicin"
                    },
                    {
                        "drugbank-id": "DB13749",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium silicate is combined with Magnesium gluconate"
                    },
                    {
                        "drugbank-id": "DB13786",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium silicate is combined with Magnesium orotate"
                    },
                    {
                        "drugbank-id": "DB13862",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium silicate is combined with Magnesium phosphate"
                    },
                    {
                        "drugbank-id": "DB13996",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium silicate is combined with Magnesium acetate"
                    },
                    {
                        "drugbank-id": "DB14077",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium silicate is combined with Magnesium stearate"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Colistin is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Botulinum Toxin Type B"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Botulinum toxin type A"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Nicotine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB08999",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Cyclopentamine"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Acetaminophen resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Propacetamol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "The therapeutic efficacy of Sorbitol can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09462",
                        "description": "The therapeutic efficacy of Glycerin can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09484",
                        "description": "The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB12942",
                        "description": "The therapeutic efficacy of Lactitol can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13526",
                        "description": "The therapeutic efficacy of Pentaerithrityl can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13707",
                        "description": "The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14482",
                        "description": "The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "The therapeutic efficacy of Potassium sulfate can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14502",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14503",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic unspecified form can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14504",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic unspecified form can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14516",
                        "description": "The therapeutic efficacy of Sodium cation can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB14546",
                        "description": "The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The absorption of Doxycycline can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The absorption of Gemifloxacin can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Miconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06395",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Abafungin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06440",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Isavuconazonium resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12073",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Albaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04794",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Bifonazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Isavuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Mephenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Ritonavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Amprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Tipranavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01264",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01319",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Fosamprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Asunaprevir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB15623",
                        "description": "Magnesium silicate can cause a decrease in the absorption of TMC 310911 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The absorption of Palbociclib can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Dexmethylphenidate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The serum concentration of Metildigoxin can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The serum concentration of Acetyldigoxin can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "The therapeutic efficacy of Cefdinir can be decreased when used in combination with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Mycophenolate mofetil resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen can cause a decrease in the absorption of Magnesium silicate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Hydroxychloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The bioavailability of Gabapentin can be decreased when combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The serum concentration of Selpercatinib can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}